HealthTree Logo
search more_vert
close
person Sign In / Create Account
Creating A New Myeloma Center of Excellence in Austin, Texas with William Matsui, MD
Creating A New Myeloma Center of Excellence in Austin, Texas with William Matsui, MD image
HealthTree Podcast for Multiple Myeloma
event Aug 20, 2019 / 11:00AM MDT

Event Description

William Matsui, MD

Dell Medical School LIVESTRONG Cancer Institutes 
Interview Date: August 20, 2019

Creating a new multiple myeloma center from scratch is a challenge, but one that Dr. William Matsui has successfully accomplished with the new myeloma center at the Austin, Texas Dell Medical School LIVESTRONG Cancer Institutes. Dr. Matsui shares what it takes to create a research lab and clinical practice for multiple myeloma in a new city. He explains how different types of research can be combined from an existing center of academic excellence - building relationships between basic researchers and those who are bringing research into clinical practice. Dr. Matsui shares how the Dell School of Medicine approaches patient care - helping the whole patient with everything that is needed such as providing treatment, emotional support, financial resources or other types of assistance in a holistic way. Dr. Matsui also describes his research to identify and target myeloma stem cells, or the cells that could be causing relapse. This show highlights the need for a myeloma specialist on your care team. Regardless of where you live, adding a myeloma specialist on your team is the single most important thing patients can do for their best outcomes. 

Thanks to our episode sponsor

 

Schedule & Agenda

person
Discussion
11:00AM
Dr. William Matsui

Speakers & Moderators

The panelist William Matsui, MD
William Matsui, MD

William Matsui, MD, is Deputy Director of the LIVESTRONG Cancer Institutes, Professor in the Department Oncology and Director of Hematological Malignancies Program at the Dell Medical School at the University of Texas at Austin. He specializes in caring for patients with cancers that involve the blood and bone marrow as well as bone marrow transplantation. He came to Austin from the Johns Hopkins University School of Medicine, where he was a professor of oncology and served as the director of the Multiple Myeloma Program and the co-director of the Division of Hematologic Malignancies. Dr. Matsui has carried out laboratory-based translational research throughout his career and focused on studying cancer stem cells, tumor cells with enhanced growth potential and their role in clinical oncology. His laboratory first identified cancer stem cells in the plasma cell malignancy multiple myeloma in 2003 and subsequently in other cancers including lymphomas, leukemias and pancreas cancer. His laboratory has also demonstrated that several pathways regulating normal stem cells, including those involved in embryonic development, are abnormally activated in cancer stem cells. Dr. Matsui completed his residency training in internal medicine at the University of Washington in Seattle and his clinical training in medical oncology at Johns Hopkins. He earned his medical degree from the University of California at San Francisco.

Read Bio
The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Sanofi
Pfizer
Regeneron
Adaptive
Bristol Myers Squibb

Follow Us

facebook instagram linkedin tiktok youtube